One Year Clinical Performance of Self Adhesive Giomer Containing Flowable Composite in Restoring Class V Cavities
NCT ID: NCT04944485
Last Updated: 2021-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
46 participants
INTERVENTIONAL
2021-08-31
2022-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of Self- Adhesive Bulk-fill Resin Composite Versus Conventionally Bonded Bulk-fill Resin Composite in Restoration of Proximal Lesions
NCT04888676
Clinical Performance of Two Different Restorative Materials in Restoring Class II Cavities of Primary Molars
NCT06000085
Performance Of Cervical Restorations Using Nitric Acid and Mineral Enriched Adhesive Versus Phosphoric Acid and Universal Adhesive
NCT05928533
Clinical Performance of Milled Resin Composite in Restoration of Endodontically Treated Posterior Teeth Over One Year
NCT04518371
Clinical Evaluation of Self-Adhesive Bulk-Fill Composite Versus Conventional Nano-hybrid Composite in Cervical Cavities
NCT06394440
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The researcher will bear ultimate responsibility for all activities associated with the conduct of a research project including recruitment of patients, explaining and performing the procedures to the patients.
Screening of patients that come to the Conservative Dentistry Department Clinic seeking dental care will continue until the target population is achieved. The patients will be subjected to full examination and diagnosis using dental charts. Once the patients that are potentially eligible for this study are identified, the patients will be contacted by the research investigator (S.M) who will explain the study and ascertains the patient's interest. If interested, more detailed evaluations and preparations are made.
Randomization will be done using simple randomization by (N.K) by generating numbers from 1:100 into two columns according to interventions/Control assessment methods. The allocation sequence will be generated using (www.randomization.com) The randomization list will be kept with (N.K) and will be kept secured away to ensure no tampering with the random list. Each participant will choose a random number from an opaque sealed envelope. When the participant chooses an envelope, it will be signed by the patient and the supervisor and the number on the envelope will be recorded in the patient chart to ensure that the patient is assigned to the randomized group The assessors, statistician and the patients will be blinded to intervention/control assessment methods; Triple blinded study. Also, it will not be allowed amongst the examiners to exchange any information throughout the entire study period.
For every patient medical and dental history will be taken. Examination charts will be filled by the investigator S.M.
Informed consent:
Patients attending at the Department of Conservative Dentistry, Faculty of Dentistry, Cairo University will be screened. Those who meet the study inclusion criteria will be recruited, will be informed with the study and an informed consent will be signed if the patients approve.
Periodontal treatment:
Periodontal treatment will be made and oral hygiene instructions will be enforced. Then, the operator will start rubber-dam isolation and cavity preparation is done as follows:
Cavity preparation procedure:
Patients will be given local anesthesia as required, and the teeth will be isolated. A No. #330 bur (0.8 mm in diameter and 1.6 mm in length) in a high speed hand piece with air /water coolant will be used to prepare class V cavity preparations. Any tooth that will suffer from pulpal exposure will be excluded from the study. Remaining caries will be excavated by a sharp excavator. A 1mm bevel will be prepared in enamel margins (Folwaczny et al., 2001). According to the concealed envelope, the tooth will be assigned to one of both treatment groups.
Control group: Selective enamel etching will be done and a universal adhesive (Prime\&Bond universal™ ,Dentsply)will be applied to both enamel and dentin. After gentle dryness and solvent evaporation the bonding agent will be cured for 20 seconds. Composite (Neo Spectra™ST, Dentsply, Sirona, USA) will be placed incrementally and light cured for 20 seconds (Noé Orellana et al., 2009)
Intervention group: Cleaning and gentle air blowing of the preparation. Then applying FIT SA F03 (Low Flow), SHOFU, USA. Spread in a thin layer (≤0.5mm) on the prepared surface with needle tip, microbrush and gently air-blow leave for 20 seconds then light cure for 5 seconds. Then, apply additional increments (≤2mm) of FIT SA and light cure each increment for 10 seconds then finish and polish.
Post curing will be done using glycerin to decrease the oxygen inhibited layer (Strnad et al.,2015). Finishing will be done using yellow and white finishing stones. More finishing and polishing will be done. Rubber-dam will be removed and patients will be recalled for evaluation after 3, 6 and 12 months. A.R and Y.S will be blinded to both treatment groups. AR and Y.S will give the restorations a score using Modified USPHS score.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
class V cavities treated with putty nanohybrid resin composite
Selective enamel etching will be done and a universal adhesive (Prime\&Bond universal™ ,Dentsply)will be applied to both enamel and dentin. After gentle dryness and solvent evaporation the bonding agent will be cured for 20 seconds. Composite (Neo Spectra™ST, Dentsply, Sirona, USA) will be placed incrementally and light cured for 20 seconds
(Neo Spectra™ ST, Dentsply, Sirona, USA)
Conventional technique using putty nanohybrid resin composite
class V cavities treated with Self adhesive giomer containing nanohybrid flowable composite
Cleaning and gentle air blowing of the preparation. Then applying FIT SA F03 (Low Flow), SHOFU, USA. Spread in a thin layer (≤0.5mm) on the prepared surface with needle tip, microbrush and gently air-blow leave for 20 seconds then light cure for 5 seconds. Then,apply additional increments (≤2mm) of FIT SA and light cure each increment for 10 seconds then finish and polish
(FIT SA F03, SHOFU, USA)
Self adhesive giomer containing nanohybrid flowable composite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
(FIT SA F03, SHOFU, USA)
Self adhesive giomer containing nanohybrid flowable composite
(Neo Spectra™ ST, Dentsply, Sirona, USA)
Conventional technique using putty nanohybrid resin composite
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No signs of irreversible pulpitis (vital teeth)
3. Young adult males or females.
4. . Acceptable oral hygiene.
5. Co-operative patients approving to participate in the study
Exclusion Criteria
2. Severe or active periodontal disease
3. Systemic diseases or severe medical complications (disabilities).
4. Lack of compliance
5. Extensive carious lesion that is in risk of pulp exposure.
6. Rampant caries.
7. History of pain or swelling.
8. Endodontically treated teeth.
9. Mobility grade 1 or 2
10. Non-carious cervical abfraction lesions
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Salma Mohamed Monir Mahmoud Ahmed
principal investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14422019423506
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.